Cardiac Biomarker Market, Size, Share, Analysis Report & Forecast to 2026

The global cardiac biomarkers market is estimated to grow at a CAGR of over 7% during the forecast period. The market growth is attributed to the rise in cardiovascular diseases coupled with the rise in the geriatric population, as the biomarkers are utilized for the detection of cardiac problems. CVD is one of the major global causes of mortality and accounted for around 18.6 million mortalities in 2019. The cardiac biomarkers are utilized to detect and measure the risk factor associated with heart diseases. The cardiac biomarkers have been successfully tested to provide a more accurate prediction of heart failure after chest pain compared to other conventional methods. This is a major factor that may fuel the growth of the market.

Free Sample Copy @ https://www.omrglobal.com/request-sample/cardiac-biomarkers-market

The global cardiac biomarker market is segmented on the basis of type, application, and location of testing. By type, the market is segmented into Creatine Kinase (CK-MB), troponins (T, I), myoglobin, ischemia modified albumin, and others.The troponin is estimated to have a considerable market share in the cardiac biomarker market due to ease and high sensitivity that results in the high adoption of the test. According to the application, the market is segmented into myocardial infarction, congestive heart failure, acute coronary syndrome, atherosclerosis, and others. By location of testing, the market is segmented into point of care (POC) testing and laboratory testing.

A Full Report of Cardiac Biomarker Market is Available at:
https://www.omrglobal.com/industry-reports/cardiac-biomarkers-market

Geographically, the study of the global cardiac biomarker market covers the analysis of four major regions including North America, Europe, Asia-Pacific, and the Rest of the World. North America is projected to contribute a prominent share in the global market. The regional growth is attributed to the increasing prevalence of cardiovascular diseases coupled with the increasing geriatric population pool. Moreover, the region has a well-established healthcare infrastructure and is home to major players operating in the market which further contribute to the regional growth of the market. 

Cardiac Biomarker Market – Segmentation
by Type
Creatine Kinase(CK-MB)
Troponins(T,I)
Myoglobin
Ischemia Modified Albumin
Others
by Application
Myocardial Infarction
Congestive Heart Failure
Acute Coronary Syndrome
Atherosclerosis
Others
by Location of Testing
Laboratory Testing
Point of Care Testing

Cardiac Biomarker Market – Segmentation by Region 
North America 
United States
Canada
Europe
Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Asia-Pacific 
China
Japan
India
Rest of Asia-Pacific
Rest of the World

Company Profiles
Abbott Laboratories Inc.
Alere Inc.
Becton, Dickson & Co.
BG Medicine Inc.
BioMérieux S.A.
Bio-Rad Laboratories Inc.
Cisbio Bioassays SAS
Creative Diagnostics
Critical Diagnostics
F. Hoffmann La Roche Ltd.
HyTest Ltd
LifeSign LLC
Luminex Corp.
Meso Scale Diagnostics LLC
Myriad RBM
Randox Laboratories Ltd.
Response Biomedical Corp.
Siemens AG
Signosis Inc.
Thermo Fisher Scientific Inc.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/cardiac-biomarkers-market

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com 
Contact no: +91 780-304-0404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.